Market Overview

What Caused The Opening Gap In Intec Pharma?


For real-time updates on NTEC, beat the news and login or try Benzinga Pro.

Intec Pharma (NYSE: NTEC) today had a large opening gap of -453.70%.

Photo taken from the Opening Gap Signals tool inside Benzinga Pro.

Why Is NTEC Moving?

Intec Pharma shares are trading lower after the company announced its Phase 3 trial of Accordion Pill-Carbidopa/Levodopa in advanced parkinson’s disease patients did not meet its target endpoints.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

For live updates on NTEC log in or try Benzinga Pro today.

Posted-In: News Intraday Update


Related Articles (NTEC)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Pain Patients Dominate Medical Cannabis Programs

Popularity of U.S. Medical-Use Markets Far Outpaces Federal Policies